Back

Risk of cardiovascular diseases in irritable bowel syndrome patients

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk in hypertensive and at-risk groups Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Luyao Li

the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an (China)

4 More presentations in this session

Presentation thumbnail
Impact of ethnicity in outcomes of major cardiovascular events in adult patients with hypertension: a meta-regression analysis of 24 randomized trials
Doctor M. Bernardi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
The impact of the esc 2024 hypertension guidelines on a population sample with a mean age of 59.56 years: a comparative analysis
Professor M. Soares Sturzeneker (Ponta Grossa, BR)
Abstract Slides Video
Presentation thumbnail
Long-term change of blood pressure and risk of major cardiovascular disease in middle-aged and older adults with prehypertension who did not take blood pressure-lowering drugs
Doctor S. Wang (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Blood pressure in young adults from the general population in Norway strongly predicts cardiovascular events after 22 years of follow-up
Doctor E. Aaseth (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk in hypertensive and at-risk groups

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Dysbiotic microbiome induce cardiac impairment by attenuating brain-derived neurotrophic factor in inflammatory bowel diseases
thumbnail
Congress Presentation
Histologic remission and major adverse cardiovascular events in patients with inflammatory bowel disease: a nationwide cohort study
thumbnail
Congress Presentation
Advanced biologic therapies are associated with fewer adverse cardiovascular events in patients with inflammatory bowel diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources